Therefore, screening the specific bacterial genus or strains and using them as additive of glycosides should remove individual difference in bioavailability of glycosides.

• 因此，筛选出具有生物转化苷类中药活性的特异性肠道细菌菌属和菌株，将之与苷类中药同时摄入，将有助于消除苷类中药在人群中应用的个体差异。